Which intraocular lens implant is best for you?

The decision of which Intraocular lens (IOL) implant implant is best for you for your cataract surgery is based on many factors and it can be overwhelming.

I hope the below information will help you make the best choice for your eyes and lifestyle.  

IOL Comparison Guide — 

Choosing the Right Intraocular Lens (IOL):

A Comprehensive Comparison Guide

By Sandra Lora Cremers, MD, FACS

Board-Certified Ophthalmologist | Cataract & Refractive Surgeon

Introduction

As a board-certified surgeon, I have done cataract surgery for over 25 years. The decision of which implant to choose as a patient—or as a surgeon for the patient—can be easy if you let your doctor know the answers to four key questions:

1. Do you want to have the best chance of not needing glasses for most activities?

2. Would you be upset if you have some halos and glare when you drive at nighttime?

3. Do you mind paying extra for a better chance at not needing progressive glasses, knowing that it is not a guarantee even if you do?

4. Where on the spectrum would you place your personality: do you consider yourself easy-going or Type A?

Answering these questions honestly helps your surgeon guide you toward the implant that best fits your lifestyle, expectations, and visual needs.

What Your Surgeon Evaluates

Your surgeon is going to look at three key components when deciding which implant to use:

1. Is your eyeball normal? Do you have a normal tear film that includes healthy meibomian glands, cornea, macula, and optic nerve—meaning you have not had any type of significant trauma? If you have diabetes, is there retinopathy, and to what extent? If you have glaucoma, how severe is it? These conditions can significantly impact which lens technology will give you the best outcome.

2. Brain function: Do you have a lazy eye (amblyopia)? If you have dementia, how severe is it? Will you understand the benefits of new-technology intraocular implants? The brain plays a critical role in interpreting the images produced by premium IOLs, particularly multifocal lenses.

3. How much corneal astigmatism do you have? The cornea is the clear window of the eye. Even a small amount of astigmatism can prevent a patient from being less reliant on glasses. Managing astigmatism is a key part of achieving the best possible uncorrected vision after surgery.

IOL Categories: Understanding Your Options

Based on the data from FDA clinical trials and published literature, I have compiled a comparison chart that I share with my patients. Below is a detailed discussion of each category of implant, including risks, benefits, and alternatives.

The Light Adjustable Lens (LAL)

In the best-case scenario, a patient who is very particular about their vision—or even a Type A personality—and perhaps has some issues with their macula or some astigmatism should consider the Light Adjustable Lens (LAL). This lens is very forgiving and often can get patients very happy with being able to see two of the three planes of vision (distance and intermediate, or intermediate and reading) very well without relying on glasses full-time.

However, it is not a perfect lens because the third plane of vision often may still require glasses in some cases, such as close-up near work. But because this lens is adjustable after implantation using UV light treatments, most patients are very happy with this implant, and the chance of needing an explant (the lens needing to be changed) is currently very low.

How the LAL Works

The Light Adjustable Lens is the only IOL that can be customized after cataract surgery. After the lens is implanted, your surgeon uses UV light treatments (called “lock-in” procedures) to precisely adjust the power of the lens based on your actual visual outcome. This means your prescription can be fine-tuned to your specific needs—something no other IOL can offer. It provides blended vision that is functional near and intermediate vs. a monofocal lens, and LAL+ improves intermediate vision vs. the original LAL design.

Key Data from the Comparison Chart

• Manufacturer: RxSight, Photoreactive Silicone

• 20/20 Distance (Uncorrected): Greater than or equal to monofocal; approximately 92% at 20/25

• Intermediate/Near Vision: Blended vision; functional near (not trifocal)

• Glare/Halos: Minimal—monofocal-like; no diffraction

• Contrast Sensitivity: No significant difference vs. monofocal

• Complications & Other Risks: UV glasses required 3–5 extra visits; 1.7% SAE; rare explants (0.7%)

• IOL Exchange Rate: Approximately 0.7%

• Approximate Cost: $3,500–$5,000+ (per eye, premium; includes LDD)

Risks of the Light Adjustable Lens

• Mandatory UV-protective glasses: You must wear special UV-blocking glasses at all times (indoors and outdoors) from the time of surgery until the final lock-in treatment is complete. Failure to do so can result in unintended changes to the lens power.

• Additional office visits: The adjustment process requires 3–5 extra office visits beyond a standard cataract surgery, which can be an inconvenience.

• Serious adverse events (SAE): Approximately 1.7% in clinical trials, including rare cases of cystoid macular edema.

• Not a multifocal: While you can achieve excellent distance and intermediate vision, you may still need reading glasses for fine print or close-up work.

• Silicone material: If future retinal surgery requiring silicone oil is needed, this could pose a complication.

• Cost: This is typically the most expensive option, ranging from $3,500 to over $5,000 per eye, and is not covered by insurance.

Benefits of the Light Adjustable Lens

• Post-operative customization means your final result is tailored to your real-world vision, not just a pre-surgical estimate.

• Minimal halos and glare—comparable to a monofocal lens—making it excellent for nighttime drivers.

• Ideal for patients with some astigmatism or mild macular issues who might not be good candidates for multifocal lenses.

• Very low explant (exchange) rate of approximately 0.7%.

• Excellent choice for Type A personalities who want maximum control and precision over their visual outcome.

Multifocal and Trifocal IOLs

The multifocal implant, for the right patients, can be transformative. Most patients are very happy with the multifocal implant because it provides vision at all three planes—distance, intermediate, and near—reducing dependence on glasses across the board.

Types of Multifocal/Trifocal IOLs

Based on the comparison chart, the following multifocal and trifocal implants are currently available:

AcrySof IQ PanOptix (Alcon, Trifocal): Approximately 73% achieve 20/20 uncorrected distance, ~50% at near, and ~73% at intermediate (2020 data, 86% in 2025). Glare is reported at ~10%, halos at ~20–30%, and ~5% report them as significant. It offers mild reduction vs. monofocal contrast sensitivity and is associated with posterior capsule opacification (Nd:YAG ~6%), reduced night contrast, and rare CME. IOL exchange rate is less than 1%, with an approximate cost of $2,500–$3,500 per eye.

Clareon PanOptix Pro (Alcon, Trifocal): Approximately 73–80% achieve 20/20 uncorrected distance, ~50–55% near, and ~75–80% intermediate (2025). Glare is ~6%, halos ~16–25%, and the Clareon platform is improved vs. the original. It offers mild reduction in contrast with fewer glistenings. Complications are similar to PanOptix but with a Clareon platform that produces less glistenings and haze. IOL exchange rate is less than 1%, with an approximate cost of $2,700–$3,800 per eye.

enVista Envy (Bausch+Lomb, Full Range): Comparable to monofocal for distance vision, with 94% reporting little-to-no difficulty near and superior to monofocal for intermediate. It features 80% less bother with glare, halos, and starbursts compared to other multifocals, and minimal contrast difference vs. monofocal (<0.15 logCS). No serious lens-related adverse events were reported in trials, and glistening-free. IOL exchange rate is less than 1% (new to market), with an approximate cost of $2,500–$3,500 per eye (estimated).

How Multifocal Lenses Work

Multifocal IOLs use diffractive rings etched onto the surface of the lens to split incoming light into multiple focal points—typically for distance, intermediate, and near vision. Your brain learns to select the appropriate image based on what you are looking at. This is why brain adaptation is so important: patients need to neuroadapt to the way these lenses divide light.

Why Macula and Tear Film Health Matters

If there is any issue with the macula (such as macular degeneration, epiretinal membrane, or diabetic macular edema) or if someone has severe dry eye disease, a multifocal IOL might not be a good option. Here is why: multifocal lenses work by splitting light into multiple focal points. If the macula is not healthy, the retina cannot clearly process the images at each focal point, leading to blurred or distorted vision that the lens cannot correct. Similarly, severe dry eye causes an unstable tear film that scatters light irregularly across the diffractive rings of the lens, resulting in increased halos, glare, and fluctuating vision. The lens depends on a smooth, stable optical surface to function optimally, and dry eye disrupts this.

Risks of Multifocal/Trifocal IOLs

• Halos and glare: The most common complaint. Approximately 10–30% of patients report noticeable halos and glare, particularly when driving at night. Most patients adapt over time, but for some, this can be persistent and bothersome.

• Reduced contrast sensitivity: All multifocal lenses cause some reduction in contrast compared to monofocal lenses because light is being split between focal points. This can be noticeable in low-light conditions.

• Posterior capsule opacification (PCO): Can occur with any IOL but may be more noticeable with multifocal lenses. Treated with a quick Nd:YAG laser procedure.

• Not reversible in the same way as LAL: Once implanted, the power cannot be adjusted. If the result is not ideal, a lens exchange surgery may be needed (though exchange rates are less than 1%).

• Cost: Ranges from approximately $2,500 to $3,800 per eye, not covered by insurance.

Benefits of Multifocal/Trifocal IOLs

• Best chance of spectacle independence across all three planes of vision: distance, intermediate, and near.

• No additional post-operative light treatments or special UV glasses required.

• High satisfaction rates for properly selected patients.

• Newer platforms like Clareon PanOptix Pro and enVista Envy offer improved optical quality with fewer side effects than earlier generation multifocals.

Extended Depth of Focus (EDOF) IOLs

EDOF lenses offer a middle ground between monofocal and multifocal lenses. They extend the range of clear vision without splitting light into distinct focal points, which typically results in fewer halos and glare compared to multifocal lenses.

Types of EDOF IOLs

Tecnis Synergy / OptiBlue (J&J Vision, Diffractive EDOF): Approximately 63% achieve 20/20 uncorrected distance, ~22% near, and ~75–77% intermediate (2025). Glare at ~3%, halos ~13–16%, starbursts ~7.9%. Slight reduction vs. monofocal contrast sensitivity, but OptiBlue is improved over the original Synergy. Complications include PCO, rare CME, some contrast loss, and it is not ideal for imperfect eyes. IOL exchange rate is less than 1%, with an approximate cost of $1,500–$2,500 per eye.

AcrySof IQ Vivity (Alcon, Non-diffractive EDOF): Approximately 69% achieve 20/20 uncorrected distance (2025 or better data), ~38–40% functional near (20/32), and ~86% intermediate (2025). Glare at ~1%, halos ~2.7%, starbursts ~1–2% (monofocal-like). Some loss at high spatial frequency, but better than multifocal IOLs. Only 1–2% report very bothersome visual disturbance, with no explants in the FDA trial. IOL exchange rate is 0% in the FDA trial, with an approximate cost of $2,500–$3,500 per eye.

Risks of EDOF IOLs

• Less near vision capability than trifocal lenses—patients may still need reading glasses for fine print.

• Some contrast sensitivity loss at high spatial frequencies compared to monofocal lenses.

• PCO and rare CME can occur, as with any IOL.

• Cost ranges from $1,500 to $3,500 per eye, not covered by insurance.

Benefits of EDOF IOLs

• Significantly fewer halos and glare compared to multifocal lenses, especially the non-diffractive Vivity.

• Good distance and intermediate vision, suitable for computer work and daily activities.

• Excellent option for patients who want some spectacle independence but are concerned about nighttime visual symptoms.

• Vivity had 0% IOL exchange rate in its FDA trial, demonstrating very high patient satisfaction.

Monofocal IOLs: The Gold Standard

The monofocal lens is the gold standard and the one covered by insurance. Most of my patients that receive this lens are happy with the quality of their vision, but they all need glasses for most of their daily work.

Key Data from the Comparison Chart

Standard Monofocal (including ZCB00, Clareon): Alcon/J&J/B+L monofocal lenses achieve approximately 80–90% 20/20 uncorrected distance (20/25 target distance only). Near and intermediate vision require reading glasses. There is no requirement for reading glasses at distance, but patients are fully dependent on progressive or reading glasses for near and intermediate work. Glare and halos are the lowest of all IOL categories (<3%), with no dysphotopsia. Best contrast sensitivity and the gold standard. PCO (Nd:YAG) may occur, rare endophthalmitis (<0.05%), and standard surgical risks. IOL exchange rate is less than 0.5%, and cost is covered by insurance ($0–$500 out of pocket).

Monovision and Mini-Monovision

Monovision and mini-monovision are alternatives for patients who want to reduce their dependence on glasses with a monofocal lens. In monovision, one eye is set for distance and the other for near. In mini-monovision, the difference between the two eyes is smaller, typically targeting one eye for distance and the other slightly for intermediate.

This can work well as long as the brain is able to tolerate the slight difference between the two eyes. Some patients are not able to tolerate it and thus need glasses full-time. A contact lens trial before surgery can help predict whether monovision will work for you.

Risks of Monofocal IOLs

• Full dependence on glasses for near and intermediate vision in most cases.

• Standard surgical risks: infection (rare endophthalmitis <0.05%), bleeding, retinal detachment, PCO.

• Monovision may cause depth perception issues or visual discomfort if the brain cannot adapt.

• No ability to adjust the lens after surgery (unlike the LAL).

Benefits of Monofocal IOLs

• Best contrast sensitivity and sharpest distance vision of any IOL category.

• Lowest incidence of halos, glare, and visual disturbances.

• Covered by insurance—no additional out-of-pocket premium cost.

• Extremely low exchange rate (<0.5%) and long track record of safety.

• Suitable for virtually all patients, including those with macular disease, glaucoma, or other ocular conditions that may limit premium IOL options.

My Personal Choice

From my own eyes—because I still do a lot of nighttime driving—I would choose the Light Adjustable Lens as halos and glare would bother me at nighttime. It is not a perfect lens, but there is no perfect lens. So given the technology available at this time, this is the land I would choose from my own eyes and current lifestyle. The ability to customize the lens after surgery gives me the precision and control that matches my personality and lifestyle.

However, if I did not do much nighttime driving, I would absolutely choose a multifocal implant because I know it gives me the best chance of not needing glasses for distance, intermediate, and reading—the trifecal “holy grail” of cataract surgery outcomes.

I would absolutely not want a monofocal lens at this point because I am dying to get rid of the need for my glasses. The freedom from spectacles is worth the premium cost and the slight trade-offs that come with advanced technology IOLs.

Final Thoughts

There is no single “best” lens for everyone. The right IOL for you depends on your eye health, your lifestyle, your tolerance for visual side effects, and your personality. The most important thing you can do is have an honest, thorough conversation with your surgeon about your expectations and daily visual demands. Together, you can make a decision that gives you the best possible outcome.

Data in this article is from FDA clinical trials and published literature. Binocular results at 6 months unless noted. Percentages are approximate. Costs vary by surgeon, region, and whether items listed are bundled. Not medical advice—consult your surgeon.

 

Sandra Lora Cremers, MD, FACS

Board-Certified Ophthalmologist

Cataract, Refractive, Glaucoma  Surgeon